Literature DB >> 23375495

[Cardiovascular adverse effects due to phenylephrine eye drops in ophtalmic surgery].

S Kauffmann1, F Commun, P Schoeffler, G Souteyrand, F Chiambaretta, P Dewachter.   

Abstract

Adverse systemic reactions such as cardiovascular effects may occur following topical ocular application of phenylephrine. We report the case of a 49-year-old woman who, following topical application of phenylephrine eyedrops, experienced hypertension with electrocardiographic modifications and a rise in cardiac troponin Ic.
Copyright © 2013. Published by Elsevier SAS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23375495     DOI: 10.1016/j.annfar.2012.12.009

Source DB:  PubMed          Journal:  Ann Fr Anesth Reanim        ISSN: 0750-7658


  3 in total

1.  Assessing the utility of 2.5% phenylephrine for diagnostic pupillary dilation.

Authors:  James C Liu; Wesley Green; Gregory P Van Stavern; Susan M Culican
Journal:  Can J Ophthalmol       Date:  2017-08       Impact factor: 1.882

2.  A Single Drop in the Eye - Effects on the Whole Body?

Authors:  Anu Vaajanen; Heikki Vapaatalo
Journal:  Open Ophthalmol J       Date:  2017-10-31

3.  Assessing the Clinical Requirement of 2.5% Phenylephrine for Diagnostic Pupil Examination.

Authors:  Junsang Cho; Brent Bruck; James C Liu; Susan M Culican
Journal:  J Ocul Pharmacol Ther       Date:  2021-03-08       Impact factor: 2.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.